Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.

Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.

Item
http://www.wikidata.org/entity/Q35576598
The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.Effects of the trace amine associated receptor 1 agonist RO5263397 on abuse-related behavioral indices of methamphetamine in ratsEffects of prior cocaine self-administration on cognitive performance in female cynomolgus monkeys.Guanfacine enhances inhibitory control and attentional shifting in early abstinent cocaine-dependent individualsAssessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine.The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in female rats.Sex differences in reinstatement of cocaine-seeking with combination treatments of progesterone and atomoxetineSubjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory StudySocial Status in Monkeys: Effects of Social Confrontation on Brain Function and Cocaine Self-Administration.The α-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals.Selective inhibition of M5 muscarinic acetylcholine receptors attenuates cocaine self-administration in rats.Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex.Carvedilol does not reduce cocaine use in methadone-maintained cocaine users.
P2860

Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.

Item
http://www.wikidata.org/entity/Q35576598
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.
@ast
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.
@en
type
label
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.
@ast
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.
@en
prefLabel
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.
@ast
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications
@en
P2093
P2860
P304
P31
P356
10.1517/13543784.2013.836488
P407
P433
P478
P50
P577
P5875
P698
P921
P932